BryoSphere Biotechnologies

BryoSphere Biotechnologies, established in 2022 and headquartered in Canada, specializes in sustainable specialty chemical manufacturing using engineered moss. The company's slogan, "Sustainable specialty chemical manufacturing using engineered moss," reflects its mission. Leveraging moss plants and biotechnology techniques, BryoSphere synthesizes rare, plant-derived specialty compounds, achieving significantly higher yields compared to their natural counterparts. This makes these compounds more accessible. Currently, the company focuses on two key products: one for addressing skin hyperpigmentation in topical treatments and another as an anti-cancer drug. In its Seed Round investment at 11 September 2023, BryoSphere Biotechnologies secured backing from SOSV and indiebio, key players in the investment landscape. With its innovative approach to biotechnology and sustainability, BryoSphere Biotechnologies presents an intriguing opportunity for venture capitalists seeking impactful and forward-thinking investments in the Biotechnology, Manufacturing, and Sustainability sectors.